Atomwise Signs US$1 B Drug Discovery Deal with Bridge Biotherapeutics
By Pratika Pahwa
Pharma Deals Review: Vol 2020 Issue 4 (Table of Contents)
Published: 6 Apr-2020
DOI: 10.3833/pdr.v2020.i4.2524 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Expanding its know-how on AI-based drug discovery, Atomwise has agreed to partner with Bridge Biotherapeutics to discover and develop up to 13 small molecule programmes across multiple therapeutic indications...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS